Leonard T. Heffner

4.0k total citations
86 papers, 1.8k citations indexed

About

Leonard T. Heffner is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Leonard T. Heffner has authored 86 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 36 papers in Genetics and 30 papers in Oncology. Recurrent topics in Leonard T. Heffner's work include Multiple Myeloma Research and Treatments (32 papers), Chronic Lymphocytic Leukemia Research (31 papers) and Lymphoma Diagnosis and Treatment (22 papers). Leonard T. Heffner is often cited by papers focused on Multiple Myeloma Research and Treatments (32 papers), Chronic Lymphocytic Leukemia Research (31 papers) and Lymphoma Diagnosis and Treatment (22 papers). Leonard T. Heffner collaborates with scholars based in United States, Germany and United Kingdom. Leonard T. Heffner's co-authors include Sagar Lonial, Jonathan L. Kaufman, Ajay K. Nooka, Lawrence Boise, Craig C. Hofmeister, Nisha S. Joseph, Madhav V. Dhodapkar, Vikas A. Gupta, David L. Jaye and Dixie‐Lee Esseltine and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Leonard T. Heffner

85 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leonard T. Heffner United States	21	996	856	784	561	464	86	1.8k
María Eugenia Sarasquete Spain	26	837 0.8×	971 1.1×	608 0.8×	401 0.7×	337 0.7×	80	1.9k
Kena C. Miller United States	18	696 0.7×	615 0.7×	468 0.6×	636 1.1×	506 1.1×	69	1.4k
Darrell White Canada	23	1.3k 1.3×	998 1.2×	1.0k 1.3×	311 0.6×	456 1.0×	134	1.9k
Ira Gupta United States	23	870 0.9×	639 0.7×	753 1.0×	719 1.3×	717 1.5×	76	2.0k
Carolina Terragna Italy	25	1.8k 1.8×	1.2k 1.4×	885 1.1×	354 0.6×	187 0.4×	99	2.3k
Carmen Chillón Spain	25	793 0.8×	715 0.8×	387 0.5×	354 0.6×	308 0.7×	76	1.5k
Thomas Moehler Germany	25	1.4k 1.4×	1.1k 1.2×	739 0.9×	281 0.5×	158 0.3×	69	2.1k
Nikolaos Anagnostopoulos Greece	17	753 0.8×	513 0.6×	474 0.6×	576 1.0×	456 1.0×	41	1.3k
Hyeon‐Seok Eom South Korea	24	530 0.5×	412 0.5×	864 1.1×	301 0.5×	679 1.5×	133	1.7k
Laurent Voillat France	20	1.9k 1.9×	1.4k 1.6×	1.3k 1.6×	261 0.5×	380 0.8×	47	2.4k

Countries citing papers authored by Leonard T. Heffner

Since Specialization

Citations

This map shows the geographic impact of Leonard T. Heffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard T. Heffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard T. Heffner more than expected).

Fields of papers citing papers by Leonard T. Heffner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard T. Heffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard T. Heffner. The network helps show where Leonard T. Heffner may publish in the future.

Co-authorship network of co-authors of Leonard T. Heffner

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard T. Heffner. A scholar is included among the top collaborators of Leonard T. Heffner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard T. Heffner. Leonard T. Heffner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joseph, Nisha S., Jonathan L. Kaufman, Madhav V. Dhodapkar, et al.. (2020). Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma. Journal of Clinical Oncology. 38(17). 1928–1937. 132 indexed citations

Hamadani, Mehdi, John Radford, Carmelo Carlo‐Stella, et al.. (2020). Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma. Blood. 137(19). 2634–2645. 122 indexed citations

Kaufman, Jonathan L., Roberto Mina, Jatin J. Shah, et al.. (2020). Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 20(12). 797–803. 5 indexed citations

Kahl, Brad S., Mehdi Hamadani, John Radford, et al.. (2019). A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma. Clinical Cancer Research. 25(23). 6986–6994. 77 indexed citations

Schmidt, Timothy M., Benjamin G. Barwick, Nisha S. Joseph, et al.. (2019). Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone. Blood Cancer Journal. 9(12). 94–94. 108 indexed citations

Mina, Roberto, Nisha S. Joseph, Jonathan L. Kaufman, et al.. (2018). Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents. Cancer. 125(3). 416–423. 34 indexed citations

Joseph, Nisha S., Charise Gleason, Leonard T. Heffner, et al.. (2017). Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM). Blood. 130. 3139–3139.

Jillella, Anand, Martha Arellano, Leonard T. Heffner, et al.. (2017). Managing Acute Promyelocytic Leukemia in Patients Belonging to the Jehovah’s Witness Congregation. Hematology Reports. 9(3). 7083–7083. 2 indexed citations

Cohen, Jonathon B., Lai Wei, Kami J. Maddocks, et al.. (2015). A Phase I Study of Gemcitabine and Bendamustine in Relapsed/Refractory Hodgkin Lymphoma. Blood. 126(23). 1496–1496. 1 indexed citations

10.

Rassi, Fuad El, Kevin C. Ward, Christopher R. Flowers, et al.. (2014). Incidence and Geographic Distribution of Adult Acute Leukemia in the State of Georgia. Southern Medical Journal. 107(8). 497–500. 2 indexed citations

11.

Nooka, Ajay K., Donald Harvey, Jonathan L. Kaufman, et al.. (2013). Using Serum Free Light Chain (SFLC) Ratio and Serum Protein Electrophoresis (SPEP) As a Substitute For 24-Hour Urine Studies In Myeloma Patients. Blood. 122(21). 5358–5358. 2 indexed citations

12.

Arellano, Martha, Suchita Pakkala, Amelia Langston, et al.. (2012). Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia. Cancer. 118(21). 5278–5282. 34 indexed citations

13.

Lamanna, Nicole, Leonard T. Heffner, Matt Kalaycio, et al.. (2012). Treatment of adults with acute lymphoblastic leukemia: Do the specifics of the regimen matter?. Cancer. 119(6). 1186–1194. 16 indexed citations

14.

Dubrey, Simon W, Donna Reece, Vaishali Sanchorawala, et al.. (2011). Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects. QJM. 104(11). 957–970. 37 indexed citations

15.

McLemore, Morgan L., Aldemar Montero, Leonard T. Heffner, et al.. (2011). Managing Chronic Myeloid Leukemia: A Coordinated Team Care Perspective. Clinical Lymphoma Myeloma & Leukemia. 12(2). 88–93. 12 indexed citations

16.

Nooka, Ajay K., et al.. (2009). Thromboembolic Events (TEE) with Lenalidomide-Based Therapies for Multiple Myeloma (MM): Emory Experience.. Blood. 114(22). 3888–3888. 1 indexed citations

17.

Winton, E., Edmund K. Waller, Leonard T. Heffner, et al.. (2008). Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma. Bone Marrow Transplantation. 42(8). 529–534. 13 indexed citations

18.

Lonial, Sagar, Martha Arellano, Amelia Langston, et al.. (2006). Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposideand cisplatin for the treatment of relapsed/refractory lymphoma. Leukemia & lymphoma. 47(10). 2155–2162. 7 indexed citations

19.

Lonial, Sagar, Timothy W. Jones, S M Devine, et al.. (2000). High Dose Chemotherapy Without Hematopoietic Cell Support for the Treatment of Refractory Lymphoma. Leukemia & lymphoma. 36(5-6). 497–502. 6 indexed citations

20.

Gordon, David, Ian Crocker, J. William Eley, et al.. (1996). High dose cyclophosphamide, fractionated total body irradiation with involved field irradiation and autologous bone marrow transplantation in malignant lymphoma. Leukemia & lymphoma. 20(3-4). 249–257. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact